NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.3 Antimetabolites > Lung cancer (non-small-cell) - pemetrexed (maintenance) - NICE TAG TA190

Lung cancer (non-small-cell) - pemetrexed (maintenance) - NICE TAG TA190

People who have received pemetrexed in combination with cisplatin as first-line chemotherapy cannot receive pemetrexed maintenance treatment.

1.1 Pemetrexed is recommended as an option for the maintenance treatment of people with locally advanced or metastatic non-small-cell lung cancer other than predominantly squamous cell histology if disease has not progressed immediately following platinum-based chemotherapy in combination with gemcitabine, paclitaxel or docetaxel.

https://www.nice.org.uk/guidance/TA190

Site by Devopa
© Copyright 2019 NHS. All rights reserved.